Mortality in schizophrenia. Antipsychotic ... - Robert Whitaker

0 downloads 124 Views 4MB Size Report
Service, Ireland. Relative risk was deter- mined as the observed ..... c n d 5 u d d t , D . o t r , C r r n r F . i ' p
PubMedmedlinequery

PageI ofl

Othernormats: ttr I I ciI"tioft_:ll*rr!.Futr.

Links: I Retated*rticles .t I Order this document

Br J Psychiatry1998Oct;173:325-9

Mortality in schizophrenia.Antipsychoticpolypharmacyand absenceof adjunctiveanticholinergicsover the courseof a 10year prospectivestudy. Waddington JL, Youssef HA, Kinsella A Departmentof Clinical Pharmacology,Royal College of Surgeonsin Ireland, Dublin. [email protected] BACKGROUND: Although increasedmortality is one of the most consistentand accepted epidemiologicalfindings in schizophrenia,a high rate of suicideappearsunableto account fully for this burdenwhich remainspoorly understood.METHOD: A cohort of 88 in-patientswas followed prospectivelyover a l0-year period and predictorsof survival sought among demographic,clinical and treatmentvariables.RESULTS: Over the decade,39 of the 88 patients(44%) died, with no instances of suicide.Reducedsurvival was predictedby increasingage,male gender,edentulousness and time sincepre-terminalwithdrawal of antipsychotics;additionally,two indicesof polypharmacypredicted reducedsurvival: maximum numberof antipsychoticsgiven concurrently(relative risk2.46,95% Cl T.l0-5.47;P : 0.03) and absenceof co-treatmentwith an anticholinergic(relativerisk 3.33, 95% CI 0.99-11.1l; P : 0.05). CONCLUSIONS:Receivingmore than one antipsychoticconcurrentlywas associatedwith reducedsurvival, in the face of little or no systematicevidenceto justify the widespreaduse of antipsychoticpolypharmacy.Conversely,over-cautiousattitudesto the use of adjunctiveanticholinergicsmay require re-evaluation. PMID: 9926037.W. 99124860

ffi ,

theabove reportin[E@l--ffi

lTgrlE rormat

.....i. documents on this pagethroughLoansomeDoc

htto://www.ncbi.nlm.nih.sov/htbin-oost/Entrelouerv?uid:9926037&form:6&db:m&Doot:b

11123199 /

( r 9 9 8 ) ,r 7 l , 3 2 5 - r 2 9

al, 1987) and lrrrve heen followcd long-

i'lortality in schizophrenia .\ntrpsychotic and absenceof adjunctive oolypharmacy

itrrdinally thereirftcr (\)uladdington cl a/, l9og, 19r-t,. Veri :;pccific iniormarit,n on

over the courseof a l0-yearprospectivestudy .intrcholinergics

t h c c i r c u n r s t a n c c so i e a c h d c : r t h r v a s t h e r c fore available. 1'he objectivc oi thc present study was to idcntifi' predictors oi reduccd

andANTHONY KINSELLA l o H N L . W A D D I N G T O N ,H A N A F Y A . Y O U S S E F

survival over a 10-ycar pcriod in circumstances that allowed isolation of nons u i c i d e - r e l a t e do r o t h e r n o n - n a t u r a l c a u s c s .

METHOD

Background Althoughincreased '' ,.r:ialrtyisone ofthe most consistent

Although

as t l o g i c a l i i n c l i n g s ( . af b l e n s k r ' , 1 9 9 . 5 ); irr the

s a t i s f i c d \ W e s h i n g t o r rI J n i v c r s i t v c n t c r i a f o r

contoxt of a disorcierhrrving;r Iifctirne p r c v a l en c e o f 0 . . 5 - 1 . 0 ' ) 1 ,a n d a r c l a t i v c

Method

A c o h o r to f 8 8 r n - p a t i e n t s

prospectivelyover a wa: follo',rred 'r'0 /r.c- _, r :o r .c - r r o da n dD r P d , lao r s o r

sirvrvalsoLLght amongdenrographrc,